No Result
View All Result
  • Login
Friday, March 6, 2026
FeeOnlyNews.com
  • Home
  • Business
  • Financial Planning
  • Personal Finance
  • Investing
  • Money
  • Economy
  • Markets
  • Stocks
  • Trading
  • Home
  • Business
  • Financial Planning
  • Personal Finance
  • Investing
  • Money
  • Economy
  • Markets
  • Stocks
  • Trading
No Result
View All Result
FeeOnlyNews.com
No Result
View All Result
Home Economy

Why Taxpayers Are Right to Reject Immoral Research

by FeeOnlyNews.com
14 hours ago
in Economy
Reading Time: 4 mins read
A A
0
Why Taxpayers Are Right to Reject Immoral Research
Share on FacebookShare on TwitterShare on LInkedIn


Whenever taxpayers object to being forced to bankroll research they consider immoral, the standard retort arrives on cue: “Don’t politicize science.” But public funding is already the politicization of science. The moment research is financed by compulsory taxation, it is no longer a purely scholarly enterprise, it becomes a state project—filtered through bureaucracies, grant incentives, and the ideological needs of the regime that signs the checks.

That is why citizens not only may but should demand cuts to public funding for research they reject—whether on moral, religious, prudential, or philosophical grounds. Not because the public must enforce one uniform morality, but because coerced funding makes everyone a participant. In a free society, you may refuse to buy what you find wicked. Under government science, you are billed anyway.

Recent Events Prove the Point: Funding Choices Are Moral and Political

Consider the US government’s newest turn on human fetal tissue. On January 22, 2026, NIH issued a policy ending the use of NIH funds for research using human fetal tissue from elective abortions, applying broadly to intramural and extramural funding mechanisms. The Associated Press described it as an expansion of restrictions from Trump’s first term, while noting that some researchers argue fetal tissue is “irreplaceable” in certain lines of biomedical inquiry.

Whether one cheers or laments the change, the crucial fact remains: the scientific establishment did not “discover” a neutral answer here. A political authority made a funding decision—about what kinds of methods and materials are acceptable for taxpayer-backed research. That is unavoidable under state patronage, and it’s intellectually dishonest to pretend otherwise.

The same pattern appears in the animal-testing arena. NIH has publicly committed to expanding “human-based” research technologies while reducing animal use, while also clarifying that animal models still have a role in the current research system. In parallel, Reuters reported that the FDA announced plans to phase out animal testing in certain drug-development contexts in favor of “human-relevant methods” such as computational models and organ-like structures.

Again: these are value-laden judgments about ethics, risk tolerance, and what counts as acceptable evidence. The public is not “corrupting science” by having opinions about them. The public is responding to the reality that government has already turned science into a public policy instrument.

Praising Past Defunding Is Not “Anti-Science”—It’s Anti-Compulsion

There is nothing incoherent about saying: “You are free to do that research—just not with my money.” That is not censorship. It is the opposite: it preserves pluralism by moving contested projects into the realm of voluntary support.

The 2019-2020 fetal-tissue episode illustrates how quickly “apolitical science” becomes a struggle over conscience. NIH’s 2019 notice added extra requirements and review considerations for extramural proposals involving fetal tissue from elective abortions. In 2020, the NIH Human Fetal Tissue Research Ethics Advisory Board reviewed 14 proposals and recommended withholding funds for 13 of them. One may dispute the board’s composition or conclusions—but the mechanism itself underscores the central truth: tax-funded research is inevitably governed by political and ethical criteria.

From a libertarian standpoint, this is not a bug, it’s a signal that the whole model is morally confused. A coerced funding system guarantees permanent conflict because it conscripts people into supporting agendas they would never choose voluntarily.

So yes—praise the defunding. Not because every defunding decision will be wise, but because every decision that shrinks coerced complicity moves society one step closer to the only stable solution: separation of science and state.

Objection: “But Then Anyone Can Defund Anything They Dislike!”

Correct—and that is precisely why public funding is such a destructive arrangement. If your neighbor may forcibly draft your income for his preferred research priorities, then you are not living under “neutral science.” You are living under an ideological tug-of-war administered by grant committees and agency heads.

Rothbard made the underlying economic point decades ago: resources are scarce, and allocating more to “science” necessarily means allocating less to other goods. In a market, those tradeoffs are disciplined by prices and voluntary demand; in a political system, they are decided by institutional power. Stephan Kinsella has argued that the “under-provision” story—only the state can fund basic research—is largely mythmaking, ignoring the historical role of private individuals and firms in producing major breakthroughs.

The deeper libertarian critique is not merely economic, it is political. Once science is patronized by the state, it becomes a career ladder, a grant economy, and a prestige machine tied to bureaucratic priorities. That is not an incidental distortion; it is the predictable result of subsidy.

Defunding Is Also a Check on the “Ministry of Opinion”

There is a second reason citizens should aggressively contest public research funding: the modern scientific establishment frequently serves as a legitimating class for state power. Rothbard’s Anatomy of the State emphasizes that the state relies on intellectuals to generate ideological support and stigmatize fundamental dissent. In a previous article, I applied that framework to academia as a “ministry of opinion,” describing how taxpayer-supported institutions can function as court intellectuals—manufacturing “consensus” that conveniently aligns with expanding administrative control.

In this light, the fight over fetal tissue and animal testing is not only about biomedical technique. It is about whether the public will continue financing a sprawling system that 1) claims moral authority; 2) demands deference (“trust the experts”); and, 3) is structurally intertwined with agencies that write rules, shape messaging, and channel public behavior.

If you want to reduce the state’s ability to mold public opinion through credentialed authority, you don’t start by begging the grant-funded priesthood to be more humble. You start by tightening the purse strings.

Expand the Cuts—Then Finish the Job

Defunding research you oppose is defensible on two levels:

Conscience: you should not be forced to subsidize what you consider wrongful;Institutional realism: public funding creates a politicized scientific class aligned with state priorities

So expand the principle. Citizens should feel free—indeed obligated—to scrutinize and oppose public funding for projects they judge unethical, wasteful, dangerous, or propagandistic. The inevitable objection—“this will politicize science”—should be met with the only serious reply: public funding already did.

But don’t stop at selective cuts. Selective cuts are a pressure valve; they are not a resolution. The resolution is structural: move scientific research to voluntary funding, competitive institutions, and genuine pluralism—where persuasion replaces compulsion, and moral disagreements don’t require political domination.

In other words, demand the defunding of what you reject today, not as a final answer, but as a step toward a society in which no one can force you to fund what you condemn—and no scientific caste can plausibly claim to speak as the “neutral” voice of the state.



Source link

Tags: immoralrejectResearchTaxpayers
ShareTweetShare
Previous Post

PB Fintech: Goldman Sachs, Tata Mutual Fund buy stake in Rs 695 crore block deal

Next Post

Novig Raises $75M to Replace the Traditional Sportsbook with a Peer-to-Peer Exchange – AlleyWatch

Related Posts

Market Talk – March 6, 2026

Market Talk – March 6, 2026

by FeeOnlyNews.com
March 6, 2026
0

ASIA: The major Asian stock markets had a mixed day today: • NIKKEI 225 increased 342.78 points or 0.62% to...

The U.S.-Iran war is already hitting consumers’ pocketbooks. Here’s how

The U.S.-Iran war is already hitting consumers’ pocketbooks. Here’s how

by FeeOnlyNews.com
March 6, 2026
0

While the U.S. war with Iran is playing out thousands of miles away, American consumers are already feeling financial ripple...

EconLog Price Theory: Housing Quantity and Price

EconLog Price Theory: Housing Quantity and Price

by FeeOnlyNews.com
March 6, 2026
0

This is the latest in our series of posts in our series on price theory problems with Professor Bryan Cutsinger....

European Parliament Accelerates DIGITAL EURO

European Parliament Accelerates DIGITAL EURO

by FeeOnlyNews.com
March 6, 2026
0

?? DIGITAL EURO MOMENT ?? Europe is accelerating the digital euro as banking stress builds. Blockchain based settlement is moving...

UAE mulls freezing Iranian assets as Middle East conflict escalates: WSJ

UAE mulls freezing Iranian assets as Middle East conflict escalates: WSJ

by FeeOnlyNews.com
March 6, 2026
0

The Damac Heights real estate development, right, in the Dubai Marina in Dubai, United Arab Emirates, on Friday, Feb. 20,...

Market Talk – March 5, 2026

Market Talk – March 5, 2026

by FeeOnlyNews.com
March 5, 2026
0

ASIA: The major Asian stock markets had a green day today: • NIKKEI 225 increased 1,032.52 points or 1.90% to...

Next Post
Novig Raises M to Replace the Traditional Sportsbook with a Peer-to-Peer Exchange – AlleyWatch

Novig Raises $75M to Replace the Traditional Sportsbook with a Peer-to-Peer Exchange – AlleyWatch

Kura Oncology Reports alt=

Kura Oncology Reports $0.92 Q4 Loss as KOMZIFTI Debuts With $2.1M in Sales

  • Trending
  • Comments
  • Latest
York IE Appoints Chuck Saia to its Strategic Advisory Board

York IE Appoints Chuck Saia to its Strategic Advisory Board

February 18, 2026
Super Bowl ads go for silliness, tears and nostalgia as Americans reel from ‘collective trauma’ of recent upheaval — ‘Everybody is stressed out’

Super Bowl ads go for silliness, tears and nostalgia as Americans reel from ‘collective trauma’ of recent upheaval — ‘Everybody is stressed out’

February 8, 2026
York IE Adds OpenView Veteran Tom Holahan as General Partner for New Early Growth Fund

York IE Adds OpenView Veteran Tom Holahan as General Partner for New Early Growth Fund

February 11, 2026
The Weekly Notable Startup Funding Report: 2/9/26 – AlleyWatch

The Weekly Notable Startup Funding Report: 2/9/26 – AlleyWatch

February 9, 2026
FPA partners with Snappy Kraken to update PlannerSearch

FPA partners with Snappy Kraken to update PlannerSearch

February 25, 2026
8 Procedures That Can Be Cheaper Without Insurance

8 Procedures That Can Be Cheaper Without Insurance

February 14, 2026
Why March 4 Marked An Institutional Bitcoin Floor

Why March 4 Marked An Institutional Bitcoin Floor

0
Is Ferrari N.V. (RACE) A Good Stock To Buy Now?

Is Ferrari N.V. (RACE) A Good Stock To Buy Now?

0
The 10 States With the Lowest (and Highest) Property Tax Rates in America

The 10 States With the Lowest (and Highest) Property Tax Rates in America

0
Why Taxpayers Are Right to Reject Immoral Research

Why Taxpayers Are Right to Reject Immoral Research

0
Stocks, rupee become casualty of war amid weak sentiment

Stocks, rupee become casualty of war amid weak sentiment

0
Tax season can bring some respite to parents with credits, deductions

Tax season can bring some respite to parents with credits, deductions

0
Why March 4 Marked An Institutional Bitcoin Floor

Why March 4 Marked An Institutional Bitcoin Floor

March 6, 2026
Stocks, rupee become casualty of war amid weak sentiment

Stocks, rupee become casualty of war amid weak sentiment

March 6, 2026
Coinbase, Microsoft, Europol Disrupt Major Phishing Platform, 330 Domains Taken Down

Coinbase, Microsoft, Europol Disrupt Major Phishing Platform, 330 Domains Taken Down

March 6, 2026
Costco Says Members May See Lower Prices if Tariff Refunds Are Issued

Costco Says Members May See Lower Prices if Tariff Refunds Are Issued

March 6, 2026
Nobel laureate Joe Stiglitz says not only can AI take your job, it’ll make the ‘tech bro’ class richer while doing so

Nobel laureate Joe Stiglitz says not only can AI take your job, it’ll make the ‘tech bro’ class richer while doing so

March 6, 2026
Market Talk – March 6, 2026

Market Talk – March 6, 2026

March 6, 2026
FeeOnlyNews.com

Get the latest news and follow the coverage of Business & Financial News, Stock Market Updates, Analysis, and more from the trusted sources.

CATEGORIES

  • Business
  • Cryptocurrency
  • Economy
  • Financial Planning
  • Investing
  • Market Analysis
  • Markets
  • Money
  • Personal Finance
  • Startups
  • Stock Market
  • Trading

LATEST UPDATES

  • Why March 4 Marked An Institutional Bitcoin Floor
  • Stocks, rupee become casualty of war amid weak sentiment
  • Coinbase, Microsoft, Europol Disrupt Major Phishing Platform, 330 Domains Taken Down
  • Our Great Privacy Policy
  • Terms of Use, Legal Notices & Disclaimers
  • About Us
  • Contact Us

Copyright © 2022-2024 All Rights Reserved
See articles for original source and related links to external sites.

Welcome Back!

Sign In with Facebook
Sign In with Google
Sign In with Linked In
OR

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Home
  • Business
  • Financial Planning
  • Personal Finance
  • Investing
  • Money
  • Economy
  • Markets
  • Stocks
  • Trading

Copyright © 2022-2024 All Rights Reserved
See articles for original source and related links to external sites.